Product Reports Resources Pricing Login Book a demo

Shockwave Medical

Biotech & Life Sciences · Santa Clara, United States · Founded 2009 · IPO 2019

Revolutionizing the interventional treatment of advanced cardiovascular disease by developing technology that targets calcified plaque

Valuation $13B
Revenue $730M
EBITDA $192M

Talent graph

Shockwave Medical's talent

Book a demo to see the people
Employees mapped 1,535 incl. 5 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 20 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

8 investors on Shockwave Medical's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 1 investor entered at this stage
Series B+ 7 investors entered at this stage
RA Capital Management
Fidelity Investments
Venrock
Ally Bridge Group
Sectoral Asset Management
Abiomed
Deerfield

Global footprint

Where Shockwave Medical has talent and traffic

Workforce by country
21 countries with
team presence
🇺🇸 United States76.8%
🇨🇷 Costa Rica11.3%
🇩🇪 Germany2.2%
🇬🇧 United Kingdom1.7%
🇮🇹 Italy1.6%
Top 5 of 21 shown
Web traffic by country
35K monthly visits
across markets
🇺🇸 United States45.4%
🇨🇦 Canada9.7%
🇩🇪 Germany8%
🇯🇵 Japan6%
🇬🇧 United Kingdom4.9%
Top 5 markets shown

Patent intelligence

$145M patent portfolio · 105 active families

Estimated portfolio value
$145M
1.2% of market cap · 2.4× smaller than top peer NovoCure ($352M)
105 active patent families
Where Shockwave Medical innovates Biomedical engineeringBlood vesselCatheterGeneral surgeryLithotripsy

Where Shockwave Medical concentrates vs peers

Each axis is a top-10 topic across Shockwave Medical and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Capital deployed

Shockwave Medical's 1 investments and acquisitions.

Every disclosed deal where Shockwave Medical appeared as a backer or acquirer, 2023–2023. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

1 deals across Shockwave Medical's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        01 · Deployment strategy vs peers

        Where Shockwave Medical deploys vs peers

        Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.

        Compare against

        02 · Portfolio market map

        Shockwave Medical's portfolio, mapped.

        Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.

        Stage
        Period
        1 of 1 deals

        Market sentiment

        What the market is saying about Shockwave Medical

        An AI-synthesized read of the highest-engagement posts about Shockwave Medical on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See Shockwave Medical on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.